MedTrace Logo

The Exploratory Study About the Effect of Using Double Filtration Plasmapheresis (DFPP) Removing Inflammatory Cytokines, Lipids and Toxic Metal Ions in Peripheral Blood in Adults

NCT06224296 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 250

Last updated 2024-01-25

No results posted yet for this study

Summary

This study investigates whether using Double Filtration Plasmapheresis (DFPP) could improve the overall health of adults through removing inflammatory cytokines, lipids and toxic metal ions from peripheral blood. It's also postulated that DFPP could boost immune cells through removing certain inflammatory cytokines and blood lipids.

Conditions

Interventions

DEVICE

DFPP

One session of blood purification using DFPP to remove inflammatory cytokines in peripheral blood.

DEVICE

DFPP

One session of blood purification using DFPP to remove lipids in peripheral blood.

DEVICE

DFPP

One session of blood purification using DFPP to remove toxic metal ions.

Sponsors & Collaborators

  • Shanghai Mengchao Cancer Hospital

    collaborator OTHER

  • Shanghai Cell Therapy Group Co.,Ltd

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
PREVENTION
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-03-01
Primary Completion
2024-12-31
Completion
2025-03-01

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06224296 on ClinicalTrials.gov